Skip to main content

Table 5 Analysis of tumour volumes detected via 7 T in vivo MRI in a CT1258 based in vivo model of prostate cancer

From: Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer

Animal

Day 23;

Day 25;

Day 39;

Day 47;

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

Tumour volume [mm3]

10

5.16

10.76

420.45

 

(♀, intact)

    

11

 

1.33

1.18

3.60

(♀, intact)

    

12

8.73

12.3

271.19

 

(♀, OHM)

    

13

19.48

29.75

148.65

 

(♀, OHM)

    
  1. The female animals received 103 MnCl2 CT1258 labelled cells. The tumour volumes are displayed for the respective days of MRI measurements after subcutaneous injection.
  2. ♀ = female animal; OHM = Ovariohysterectomised.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us